Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials
Ramos-Esquivel, Allan, Hernández-Steller, Hellen, Savard, Marie-France, Landaverde, Denis UlisesLanguage:
english
Journal:
Breast Cancer
DOI:
10.1007/s12282-018-0848-6
Date:
February, 2018
File:
PDF, 1.45 MB
english, 2018